statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Independent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure's ProSense, Adding to Continued Positive Data Published Globally...

Independent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure's ProSense, Adding to Continued Positive Data Published Globally

As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response PR Newswire...

As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response

IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing...

IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing Authorization to Treat Early-Stage Breast Cancer

IceCure Medical Reports Full Year 2023 Financial Results: Global ProSense and Disposables Sales Increase 26% as Company Continues Transition to Commercial Phase and Expects to Submit ICE3 Breast...

IceCure Medical Reports Full Year 2023 Financial Results: Global ProSense and Disposables Sales Increase 26% as Company Continues Transition to Commercial Phase and Expects to Submit ICE3 Breast Cancer Study Data to FDA this Month for Marketing Clearance

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

IceCure Medical files submission to FDA for clearance of its XSense System

IceCure Submits FDA Regulatory Filing for New XSense Cryoablation System with Cryoprobes IceCure Submits FDA Regulatory Filing for New XSense Cryoablation System with Cryoprobes PR Newswire CAESAREA...

IceCure Submits FDA Regulatory Filing for New XSense Cryoablation System with Cryoprobes

IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024 IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024 PR Newswire...

IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024

IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a...

IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a Non-Surgical Alternative to Lumpectomy

IceCure Medical receives Notice of Allowance from Japan Patent Office

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient Outcomes IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow...

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient Outcomes

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Watchers	1,942
52-Wk Low	$0.52
52-Wk High	$1.57

Volume	288,403.00
52-Wk High	$1.57
52-Wk Low	$0.52

ICCM Icecure Medical Ltd

About

Feed

News

Earnings

Fundamentals